Table 3.
Variable | UNIVARIATE ANALYSIS | MULTIVARIATE ANALYSIS MODEL 1* | MULTIVARIATE ANALYSIS MODEL 2† | |||
---|---|---|---|---|---|---|
UNADJUSTED HR VALUE (95% CI) | P- | ADJUSTED HR VALUE (95% CI) | P- | ADJUSTED HR VALUE (95%CI) | P- | |
Age (5 year increments) | 1.1 (0.9–1.5) | 0.28 | --- | --- | --- | --- |
Gender | 1.8 (0.5–6.2) | 0.39 | --- | --- | --- | --- |
NYHA functional class | 2.0 (0.8–4.5) | 0.12 | 2.7 (1.0–7.2) | 0.04 | 2.6 (1.0–7.0) | 0.05 |
CMR LVEDV index (ml/m2) (per 10 ml/m2 increments) | 1.1 (1.0–1.2) | 0.08 | --- | --- | 1.0 (0.9–1.1) | 0.70 |
Presence of CMR LGE (vs absence) | 7.1 (2.0–25.4) | 0.002 | 8.6 (2.4–31.6) | 0.001 | 8.2 (2.2–30.9) | 0.002 |
Excluding patients with CAD | ||||||
Age (5 year increments) | 1.2 (0.9–1.6) | 0.17 | --- | --- | --- | --- |
Gender | 1.9 (0.5–6.8) | 0.33 | --- | --- | --- | --- |
NYHA functional class | 1.8 (0.8–4.4) | 0.17 | --- | --- | 2.1 (0.8–5.5) | 0.15 |
CMR LVEDV index (ml/m2) (per 10 ml/m2 increments) | 1.1 (1.0–1.2) | 0.14 | --- | --- | 1.0 (0.9–1.1) | 0.9 |
Presence of CMR LGE (vs absence) | 8.9 (2.4–32.2) | 0.001 | 8.9 (2.4–32.2) | 0.001 | 9.2 (2.4–35.1) | 0.001 |
For Model 1 (parsimonious model), forward stepwise regression (p<0.10 for entry, p>0.05 for removal) was used to arrive at a parsimonious model.
For Model 2, NYHA functional class, CMR LVEDV index, and LGE fibrosis were all entered into the multivariate model.